Scott R. Ward, Director at MAP Pharmaceuticals, Inc. (MAPP), bought 2,000 shares at $15.69 ($31K) on 2011-03-11, disclosed to the SEC on 2011-03-15.
Open-market purchase of $31k MAPP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| MDT | SELL | 2007-06-04 | $196K | — | Filing → |
| MDT | SELL | 2007-04-18 | $13K | — | Filing → |
| MDT | SELL | 2007-04-17 | $13K | — | Filing → |